NZ203364A - Method for purifying human immune interferon;homogeneous human immune interferon - Google Patents

Method for purifying human immune interferon;homogeneous human immune interferon

Info

Publication number
NZ203364A
NZ203364A NZ203364A NZ20336483A NZ203364A NZ 203364 A NZ203364 A NZ 203364A NZ 203364 A NZ203364 A NZ 203364A NZ 20336483 A NZ20336483 A NZ 20336483A NZ 203364 A NZ203364 A NZ 203364A
Authority
NZ
New Zealand
Prior art keywords
human immune
immune interferon
column
interferon
homogeneous
Prior art date
Application number
NZ203364A
Other languages
English (en)
Inventor
S Stein
R A Wolfe
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NZ203364A publication Critical patent/NZ203364A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ203364A 1982-03-01 1983-02-22 Method for purifying human immune interferon;homogeneous human immune interferon NZ203364A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35344282A 1982-03-01 1982-03-01

Publications (1)

Publication Number Publication Date
NZ203364A true NZ203364A (en) 1986-07-11

Family

ID=23389118

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ203364A NZ203364A (en) 1982-03-01 1983-02-22 Method for purifying human immune interferon;homogeneous human immune interferon

Country Status (19)

Country Link
EP (1) EP0087686A3 (enExample)
JP (1) JPS58159417A (enExample)
KR (1) KR840003422A (enExample)
AU (1) AU1181283A (enExample)
DK (1) DK104283A (enExample)
ES (1) ES520164A0 (enExample)
FI (1) FI830557L (enExample)
GB (1) GB2119383A (enExample)
GR (1) GR77910B (enExample)
GT (1) GT198301619A (enExample)
IL (1) IL67978A0 (enExample)
MC (1) MC1499A1 (enExample)
MT (1) MTP924B (enExample)
MW (1) MW783A1 (enExample)
NO (1) NO830697L (enExample)
NZ (1) NZ203364A (enExample)
PT (1) PT76310B (enExample)
ZA (1) ZA83768B (enExample)
ZW (1) ZW4683A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3381553D1 (de) * 1982-10-25 1990-06-21 Genentech Inc Synergistische humaninterferonaktivitaet.
IL67896A (en) * 1983-02-13 1987-03-31 Yeda Res & Dev Two biologically active human gama interferon subtypes,purification thereof and pharmaceutical compositions containing them
EP0133767B1 (en) * 1983-08-04 1991-04-03 The Green Cross Corporation Gamma interferon composition
US4681930A (en) * 1983-09-20 1987-07-21 Hoffmann-La Roche Inc. Immune interferon and a method for its extraction and purification
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
US4946674A (en) * 1984-10-05 1990-08-07 Bioferon Biochemische Substanzen Gmbh & Co. Process for treatment of rheumatic diseases
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
NO861139L (no) * 1985-03-25 1986-09-26 Schering Corp Stabilt gamma-interferonpreparat.
GB8508340D0 (en) * 1985-03-29 1985-05-09 Creighton T E Production of protein
GB8522336D0 (en) * 1985-09-09 1985-10-16 Biogen Nv Composition for treatment of allergies
EP0302862A1 (en) * 1986-03-17 1989-02-15 Schering Corporation Treatment of cancers with gamma interferon
IL84170A0 (en) * 1986-10-17 1988-03-31 Interferon Sciences Inc Method for detecting interferon
ATE74517T1 (de) * 1987-01-20 1992-04-15 Schering Corp Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
DE102007050165B4 (de) * 2007-10-19 2010-06-17 Stiftung Tierärztliche Hochschule Hannover Stabilisierte Lösung, Verfahren zu deren Herstellung sowie deren Verwendung und Arzneimittel in Form einer stabilisierten Lösung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA120527A (en) * 1907-05-18 1909-09-14 James Mccallum Robertson Prepay device for meters
CA120526A (en) * 1909-05-05 1909-09-14 Robert A. Reynolds Internal combustion engine
CA130300A (en) * 1910-08-03 1911-01-03 John W. Ziegler Current wheel
CA154712A (en) * 1914-01-02 1914-03-31 William Francis Fox Photographic process
CA179241A (en) * 1917-03-02 1917-09-11 John Totterdale Container
US4241174A (en) * 1978-11-24 1980-12-23 Hoffmann-La Roche Inc. Interferon assay
IN150740B (enExample) * 1978-11-24 1982-12-04 Hoffmann La Roche
ZA803943B (en) * 1979-07-31 1981-06-24 Hoffmann La Roche Homogeneous fibroblast interferon and method for manufacture thereof

Also Published As

Publication number Publication date
AU1181283A (en) 1983-09-08
NO830697L (no) 1983-09-02
ES8407499A1 (es) 1984-10-01
PT76310B (en) 1986-02-12
DK104283D0 (da) 1983-02-28
GB8305506D0 (en) 1983-03-30
PT76310A (en) 1983-03-01
GT198301619A (es) 1984-08-21
JPS58159417A (ja) 1983-09-21
ZW4683A1 (en) 1983-10-19
MC1499A1 (fr) 1983-11-17
EP0087686A2 (en) 1983-09-07
GR77910B (enExample) 1984-09-25
EP0087686A3 (en) 1985-09-18
MTP924B (en) 1984-05-03
FI830557A0 (fi) 1983-02-18
KR840003422A (ko) 1984-09-08
IL67978A0 (en) 1983-06-15
ES520164A0 (es) 1984-10-01
DK104283A (da) 1983-09-02
FI830557A7 (fi) 1983-09-02
ZA83768B (en) 1983-10-26
GB2119383A (en) 1983-11-16
FI830557L (fi) 1983-09-02
MW783A1 (en) 1984-09-12

Similar Documents

Publication Publication Date Title
Yip et al. Partial purification and characterization of human gamma (immune) interferon.
NZ203364A (en) Method for purifying human immune interferon;homogeneous human immune interferon
DK161048B (da) Fremgangsmaade til fremstilling af humant interferon
US5196323A (en) Process for preparing and purifying alpha-interferon
US4551271A (en) Purification of interferon by metal chelate chromatography
US4278661A (en) Purification of interferon
US4765903A (en) Purification of monomeric interferon
FI70721C (fi) Foerfarande foer framstaellning av maenskligt fibroblast-interferon som homigent protein
US4617378A (en) Purification of biologically active human immune interferon
US4908432A (en) Novel polypeptide having gamma-interferon activity
CA1340281C (en) Process for preparing and purifying alpha-interferon
JPS6261040B2 (enExample)
IL90975A (en) Non-glycosylated, recombinant human il2 in reduced form, the process for obtaining it and its use as a medicament
Kenny et al. [64] Purification of human fibroblast interferon produced in the absence of serum by cibacron blue F3GA-agarose and high-performance liquid chromatography
EP0071647B1 (en) Process for recovering interferon
Rubinstein et al. [67] Purification and characterization of human leukocyte interferons by high-performance liquid chromatography
Friesen et al. [63] Purification of human fibroblast interferon by high-performance liquid chromatography
EP0396555A1 (en) PURIFICATION OF INTERFERON MONOMER.
EP0446850A2 (en) Process for purifying recombinant human beta-interferon
TRAUB et al. Isolation of Two Species of Human Lymphoblastoid (Namalva) Cell-Derived Interferon that Differ in Rates of Clearance, Size, and Cell Specificity.
Herring et al. Rapid purification of leukocyte interferons by high-performance liquid chromatography
Cohen et al. [21] Induction and characterization of bovine leukocyte interferon
HU201100B (en) Process for large-scale production of high purity human leukocyte alpha interferon with reduced endotoxin content and with improved therapeutic effect
Ferreira pUICATION OF HUMAN AMNIOTIC MEMBRANE INTERFERON BY
JPS61207334A (ja) 腫瘍細胞障害性物質